These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23998977)

  • 21. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gastro-oesophageal reflux disease-update 2021].
    Labenz J; Borkenstein DP; Müller M; Labenz G
    Internist (Berl); 2020 Dec; 61(12):1249-1263. PubMed ID: 33112963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors.
    Woodland P; Sifrim D
    Curr Opin Gastroenterol; 2013 Jul; 29(4):431-6. PubMed ID: 23549342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
    Tonini M; De Giorgio R; De Ponti F
    Drugs; 2004; 64(4):347-61. PubMed ID: 14969571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview: initial and long-term management of gastro-oesophageal reflux disease.
    Dent J; Talley NJ
    Aliment Pharmacol Ther; 2003 Feb; 17 Suppl 1():53-7. PubMed ID: 12614307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastro-oesophageal reflux disease.
    de Carle DJ
    Med J Aust; 1998 Nov; 169(10):549-54. PubMed ID: 9861914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.
    Sifrim D; Zerbib F
    Gut; 2012 Sep; 61(9):1340-54. PubMed ID: 22684483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
    Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
    Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    Vakil N
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The modern investigation and management of gastro-oesophageal reflux disease (GORD).
    Banks M
    Clin Med (Lond); 2009 Dec; 9(6):600-4. PubMed ID: 20095310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastro-oesophageal reflux disease.
    Fass R; Boeckxstaens GE; El-Serag H; Rosen R; Sifrim D; Vaezi MF
    Nat Rev Dis Primers; 2021 Jul; 7(1):55. PubMed ID: 34326345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastro-oesophageal reflux disease.
    Moayyedi P; Talley NJ
    Lancet; 2006 Jun; 367(9528):2086-100. PubMed ID: 16798392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?
    Lee TJ; Fennerty MB; Howden CW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1241-51. PubMed ID: 15606386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.
    Gawrieh S; Shaker R
    Drugs Aging; 2003; 20(7):509-16. PubMed ID: 12749748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the available treatments for non-erosive reflux disease.
    Labenz J; Morgner-Miehlke A
    Expert Opin Pharmacother; 2006 Jan; 7(1):47-56. PubMed ID: 16370921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management.
    Argüero J; Sifrim D
    Nat Rev Gastroenterol Hepatol; 2024 Apr; 21(4):282-293. PubMed ID: 38177402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
    Kahrilas PJ; Boeckxstaens G
    Gut; 2012 Oct; 61(10):1501-9. PubMed ID: 22684485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.